MICHAEL JAMES OVERMAN to Hematologic Diseases
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Hematologic Diseases.
Connection Strength
0.071
-
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors. Cancer Invest. 2008 Oct; 26(8):794-9.
Score: 0.071
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.